NCT02638584View on ClinicalTrials.gov

Effects of Ilaprazole on Ulcer Healing Rate and Prevention of Gastrointestinal Bleeding in the Patients Undergone ESD.

PHASE4CompletedINTERVENTIONAL
Enrollment

176

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

March 31, 2018

Study Completion Date

March 31, 2018

Conditions
Gastric Cancer
Interventions
DRUG

Ilaprazole

Ilaprazole 10mg 2tablets once a day(1 times / day), before breakfast

DRUG

Rabeprazole

Rabeprazole 20mg 1tablets once a day(1 times / day), before breakfast

Trial Locations (1)

Unknown

HALLYM UNIVERSITY MEDICAL CENTER, Chuncheon Sacred Heart Hospital, Chuncheon

All Listed Sponsors
lead

Il-Yang Pharm. Co., Ltd.

INDUSTRY

NCT02638584 - Effects of Ilaprazole on Ulcer Healing Rate and Prevention of Gastrointestinal Bleeding in the Patients Undergone ESD. | Biotech Hunter | Biotech Hunter